Navigation Links
UB's bioblower closer to protecting soldiers from biological attack
Date:2/28/2008

BUFFALO, N.Y. -- A powerful air sterilization technology developed at the University at Buffalo has killed every biological agent with which it has been challenged, including airborne spores, viruses and bacteria in independent tests conducted for the U.S. Department of Defense.

A prototype produced by Buffalo BioBlower Technologies LLC, a UB spin-off company, destroyed biological agents to a level of better than one part per million in an independent evaluation conducted over a period of four weeks by the Research Triangle Institute for the U.S. Department of Defense Joint Program for Chemical and Biological Defense Collective Protection.

In a related development, UB recently received a Notice of Allowance, indicating that a U.S. patent will issue soon covering the BioBlower technology.

Everything from hospitals, first-responder units and postal facilities to government buildings and mass-transit systems could benefit enormously from the security and peace of mind generated by this device, said Rep. Louise M. Slaughter. Once again, our region is serving as a leader in technological development, and it is this labor and innovation that are benefiting people both locally and throughout our country.

The positive outcomes in the independent evaluation indicate that BioBlower could, in the near future, be protecting soldiers from biological attack, according to James F. Garvey, Ph.D., professor in the Department of Chemistry in the UB College of Arts and Sciences and co-founder and chief technical officer of Buffalo BioBlower Technologies, with John Lordi, Ph.D., chief executive officer.

Lordi is a research professor in the Department of Mechanical and Aerospace Engineering in the UB School of Engineering and Applied Sciences. James D. Felske, Ph.D., and Joseph C. Mollendorf, Ph.D., professors in the same department, are co-inventors with Garvey and Lordi.

This independent third-party validation of our technology was so exceptionally compelling that the military has now directed us to retrofit one of their existing platforms with a BioBlower as a technology demonstration, Garvey said.

The military system now being retrofitted with BioBlower is used to inflate the hospital units and temporary shelters erected in the battlefield for command headquarters.

Were removing their current fan and replacing it with our electrical air pump, the BioBlower, which also will instantly kill any airborne biological agents on contact, Garvey said.

Conventional technologies involve the use of HEPA (High-Efficiency Particulate Air) filters, which simply trap large airborne spores. These passive filters have to be regularly replaced and properly discarded, posing a further potential hazard to personnel, Garvey said. In addition, they provide little or no protection against airborne viruses.

Right now, its up to soldiers in the field to swap out these filters and replace them, which involves considerable logistic demands, such as labor and expense, said Garvey.

In contrast, he noted, the BioBlower immediately kills any and all airborne biological pathogens and only electricity is needed to power the rotary air pump, which drives the blower.

With the BioBlower, theres nothing to replace and no maintenance, said Garvey. Its really plug and play. You plug in the machine and as long as its running, its doing its job.

BioBlower units are inherently scalable, said Garvey, and can be installed as a permanent part of a building's air-handling (HVAC) system, including on military bases.

The technology also has potential applications in health-care and hospital settings to ensure a sterile environment. The New York State Foundation for Science, Technology and Academic Research currently is funding development of a BioBlower prototype for health-care settings with the goal of taking it into clinical trials.

BioBlower also has application to the home health-care setting, a market poised to experience tremendous growth in coming years, said Garvey, who adds that a small portable unit could completely sterilize all of the air in any room in the house.

The BioBlower technology moved out of UBs laboratories and into the commercialization phase thanks to funding from several sources, including the U.S. Department of Defense, secured by U.S. Rep. Louise M. Slaughter; UBs Office of Science Technology and Economic Outreach; NYSTAR and the UB Center for Advanced Biomedical and Bioengineering Technology, part of UB's New York State Center of Excellence in Bioinformatics and Life Sciences, where Buffalo BioBlower Technologies is based.

BioBlower is based on a modification of a Roots blower, a mechanical air-pump technology, which has been in existence for more than 100 years and has been used for a range of applications from vacuum pumps in research laboratories to superchargers for drag-racing "funny cars."

The BioBlower destroys airborne pathogens by rapidly heating the contaminated air under pressure and mechanically compressing it as it is being blown rapidly through the mechanical rotary pump. The system then blows the disinfected air back into the enclosed environment whether it is a tank, plane, ship, tent or building.


'/>"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-5000 x1415
University at Buffalo
Source:Eurekalert

Related medicine news :

1. UGA researchers 1 step closer to elusive cancer vaccine
2. Research Gets Closer to Origin of Parkinsons Disease
3. Study Gets Closer to Origins of Leukemia
4. Bug guts map brings scientists closer to understanding different bugs role in the body
5. APHA Urges President Bush Not To Veto CHIP; Were Only One Signature Away from Protecting the Health of Our Children
6. Medical identity theft: the importance of protecting your health records
7. National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage
8. Doctors, economist, write prescription for protecting people from themselves
9. Congressman Tom Reynolds Awarded for Protecting Medicare Choices
10. OHSU research suggests new strategy for protecting aging Americans against infectious disease
11. An emerging candidate for protecting patients from liver injury after abdomen surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is happy ... KlipPro KP-240L clipper is available to the public. This is an unusual clipper because ... than the average clipper. , Everything about this product is concentrated on ease of ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can be ... a preset onto their media," said Christina Austin - CEO of Pixel Film Studios. ... quickly and easily add stylish color grades to their footage. A LUT is a ...
(Date:5/28/2016)... ... ... the city where’s it’s easy to spot the neon lights of chains serving fast food, ... with a taste for real food. , On May 13, the Best Western ... casual restaurant focusing on dishes made by hand with wholesome, organic ingredients that are sourced ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue ... Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in ... Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... PUNE, India , May 27, 2016 ... in the instances of hypertension is driving ambulatory blood ... muscles lose their elasticity and their ability to respond ... blood pressure. This condition can lead to various cardiovascular ... and peripheral vascular disease. These diseases are growing in ...
(Date:5/26/2016)... , May 26, 2016 According ... "Medical Waste Management Market - U.S. Industry Analysis, Size, Share, ... management market in the U.S. was valued at US$ 5.89 ... CAGR of 3.4% from 2015 to 2023 to reach US$ ... analysis of current and emerging needle free drug delivery devices ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology: